article thumbnail

Global Survey Highlights Drug Development Challenges and Opportunities

PPD

The PPD clinical research business of Thermo Fisher Scientific has conducted a comprehensive survey involving 150 drug developers from around the world. This initiative, now in its third year, is designed to provide a detailed assessment of current drug development practices and shifts within the industry.

article thumbnail

Key Trends Drug Developers Need to Know to Succeed

PPD

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.

article thumbnail

The Essential Roadmap to Drug Development for Bioanalytical Success

Fierce BioTech

The Essential Roadmap to Drug Development for Bioanalytical Success Discover the 3 pillars of successful PK testing and conquer bioanalytical challenges with this whitepaper’s insights. Download now.

article thumbnail

Increasing the probability of technical success in drug development using AI and patient heterogeneity

Predictive Oncology

By combining these two assets, this offering represents an opportunity to de-risk drug discovery and accelerate pipeline development. Complete the form below to download the white paper.

article thumbnail

A Proactive Drug Development Solution for Your Biologics

Alta Sciences

A Proactive Drug Development Solution for Your Biologics nbartlett Thu, 07/20/2023 - 15:37 HTML The process of biologic drug development, from lead molecule identification to approval, can be long and complicated. Download now. Altasciences is here to help streamline the process. Fact Sheet: Biologics/Biosimilars.

article thumbnail

Accelerating Global Drug Development Timelines With Ethnobridging

Alta Sciences

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B.

article thumbnail

How next-generation phage display libraries are accelerating antibody developability

Fierce BioTech

How next-generation phage display libraries are accelerating antibody developability Download now to learn how a next-generation phage library is overcoming the limitations of traditional antibody discovery platforms, enhancing the discovery of highly specific and effective antibody-based therapies.